PED(PED)
PED
$13.70—Stale · unknown old
NYSE • Last print unknown ago
$13.70—Stale · unknown old
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $143M | $141M |
| Low | $140M | $136M |
| High | $146M | $146M |
| EBITDA Avg | $21M | $28M |
| Low | $21M | $27M |
| High | $21M | $29M |
| EBIT Avg | $2M | $7M |
| Low | $2M | $7M |
| High | $2M | $8M |
| Net Income Avg | $1M | $6M |
| Low | $992,514 | $5M |
| High | $1M | $6M |
| EPS Avg | $0.22 | $1.19 |
| Low | $0.22 | $1.04 |
| High | $0.23 | $1.34 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $31M | $30M | $34M | $34M | $36M | $38M |
| Low | $30M | $29M | $32M | $32M | $34M | $36M |
| High | $32M | $32M | $35M | $36M | $37M | $40M |
| EBITDA Avg | $15M | $14M | $16M | $15M | $16M | $17M |
| Low | $14M | $13M | $16M | $15M | $15M | $16M |
| High | $15M | $14M | $16M | $16M | $16M | $17M |
| EBIT Avg | $5M | $4M | $7M | $6M | $7M | $8M |
| Low | $4M | $4M | $6M | $6M | $6M | $7M |
| High | $5M | $4M | $7M | $6M | $7M | $8M |
| Net Income Avg | $2M | $2M | $4M | $3M | $4M | $5M |
| Low | $2M | $2M | $4M | $3M | $4M | $4M |
| High | $3M | $2M | $4M | $4M | $4M | $5M |
| EPS Avg | $0.18 | $0.14 | $0.29 | $0.26 | $0.29 | $0.35 |
| Low | $0.16 | $0.12 | $0.27 | $0.24 | $0.27 | $0.33 |
| High | $0.20 | $0.16 | $0.31 | $0.28 | $0.31 | $0.38 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |